Summary
Bristol-Myers Squibb Company (BMY) filed an 8-K on March 4, 2010, primarily to report on a press release issued in conjunction with an investor meeting. The key takeaway for investors is the company's announcement of minimum non-GAAP earnings per share (EPS) guidance for the year 2013. This forward-looking guidance provides a specific financial target for a future period, offering investors a measure of the company's expected performance. It is important to note that this guidance is non-GAAP, meaning it excludes certain items from generally accepted accounting principles. The company also stated that there is no reasonably accessible or reliable comparable GAAP measure for this information, emphasizing the need for investors to understand the nature of the provided guidance.
Key Highlights
- 1BMY announced minimum non-GAAP EPS guidance for 2013.
- 2The guidance was provided during an investor meeting.
- 3The announcement was made via a press release dated March 4, 2010.
- 4The guidance is subject to certain exclusions and assumptions.
- 5The company noted the lack of a comparable GAAP measure for this forward-looking information.
- 6The filing is an 8-K report, indicating an event of significant importance to the company.